Hong Li

Dr. Hong Li serves as an Associate Professor in the School of Science at RMIT University. His research focuses on leveraging computational modeling and network pharmacology to investigate the clinical effects and mechanisms of natural products for cancers, infectious diseases, and metabolic disorders. Dr. Li's work emphasizes synergistic effects of herbal compounds and their integration with conventional therapies, particularly in prostate cancer treatment. He has secured significant research funding, including grants from the National Natural Science Foundation of China and the Guangdong Basic and Applied Basic Research Foundation. His professional contributions include editorial roles for Traditional Medicine Research and peer-review activities for high-impact journals like Frontiers in Pharmacology and Evidence-based Complementary and Alternative Medicine. In 2021, he was awarded the Deputy Vice-Chancellor’s Higher Degree by Research Prize for academic excellence.

Dr. Li’s research spans multiple disciplines including medicinal chemistry, pharmacology, oncology, and integrative medicine. His computational approaches involve supercomputing simulations, molecular docking studies, and metabolomic profiling to uncover drug discovery opportunities. Current projects explore synergies between herbal formulas (e.g., Danggui Beimu Kushen Wan) and conventional drugs like abiraterone for castrate-resistant prostate cancer treatment. His work bridges traditional Chinese medicine practices with modern biomedical research methodologies.